Windtree Therapeutics Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company
Key Highlights
Windtree Therapeutics Inc (Windtree Therapeutics) is a biopharmaceutical and medical device company that focuses on developing its drug product candidates for the treatment of pulmonary and cardiovascular diseases. The company’s four lead development programs are istaroxime, for treating acute decompensated heart failure (ADHF); Aerosurf, a lucinactant for inhalation, and lyophilized KL4 surfactant intratracheal suspension, both for treating respiratory distress syndrome (RDS) in premature infants; and rostafuroxin for treating genetically associated hypertension. The company uses its proprietary technology platform Aerosol Delivery System (ADS) with pulmonary surfactants or in combination with other products to treat pediatric and adult respiratory disorders. Windtree Therapeutics is headquartered in Warrington, Pennsylvania, the US.
Scope
- Detailed information on Windtree Therapeutics Inc required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Windtree Therapeutics Inc in the form of a SWOT analysis
- An in-depth view of the business model of Windtree Therapeutics Inc including a breakdown and examination of key business segments
- News about Windtree Therapeutics Inc, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
- Gain understanding of Windtree Therapeutics Inc and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Windtree Therapeutics Inc as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on Windtree Therapeutics Incs business structure, strategy and prospects.
Note: Some sections may be missing if data is unavailable for the company.
Companies mentioned
Takeda UK Ltd
Sandoz Ltd
RespireRx Pharmaceuticals Inc
Ony Inc
Chiesi Farmaceutici SpA
ANI Pharmaceuticals Inc
Takeda UK Ltd
Sandoz Ltd
RespireRx Pharmaceuticals Inc
Ony Inc
Chiesi Farmaceutici SpA
ANI Pharmaceuticals Inc
Table of Contents
Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 - About the Company
Windtree Therapeutics Inc - Key Facts
Windtree ...
Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 - About the Company
Windtree Therapeutics Inc - Key Facts
Windtree Therapeutics Inc - Key Employees
Windtree Therapeutics Inc - Key Employee Biographies
Windtree Therapeutics Inc - Major Products and Services
Windtree Therapeutics Inc - History
Windtree Therapeutics Inc - Company Statement
Windtree Therapeutics Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Windtree Therapeutics Inc - Business Description
Windtree Therapeutics Inc - SWOT Analysis
SWOT Analysis - Overview
Windtree Therapeutics Inc - Strengths
Windtree Therapeutics Inc - Weaknesses
Windtree Therapeutics Inc - Opportunities
Windtree Therapeutics Inc - Threats
Windtree Therapeutics Inc - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Windtree Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Windtree Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Windtree Therapeutics Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Aug 14, 2019: Windtree Therapeutics reports second quarter 2019 financial results and provides key business updates
May 20, 2019: Windtree Therapeutics reports first quarter 2019 financial results and provides key business updates
Apr 30, 2019: Windtree Therapeutics appoints Daniel Geffken to Board of Directors
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
List of Tables
Windtree Therapeutics Inc, Key Facts
Windtree Therapeutics Inc, Key Employees
Windtree Therapeutics Inc, Key Employee Biographies
Windtree Therapeutics Inc, Major Products and ...
List of Tables
Windtree Therapeutics Inc, Key Facts
Windtree Therapeutics Inc, Key Employees
Windtree Therapeutics Inc, Key Employee Biographies
Windtree Therapeutics Inc, Major Products and Services
Windtree Therapeutics Inc, History
Windtree Therapeutics Inc, Other Locations
Windtree Therapeutics Inc, Subsidiaries
Windtree Therapeutics Inc, Key Competitors
Windtree Therapeutics Inc, Ratios based on current share price
Windtree Therapeutics Inc, Annual Ratios
Windtree Therapeutics Inc, Annual Ratios (Cont...1)
Windtree Therapeutics Inc, Interim Ratios
Windtree Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Windtree Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Windtree Therapeutics Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
List of Figures
Windtree Therapeutics Inc, Performance Chart (2014 - 2018)
Windtree Therapeutics Inc, Ratio Charts
Windtree Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, ...
List of Figures
Windtree Therapeutics Inc, Performance Chart (2014 - 2018)
Windtree Therapeutics Inc, Ratio Charts
Windtree Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Windtree Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019